Colin R Dormuth

8PUBLICATIONS
13CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Regenerative medicine (incl. stem cells)AutoimmunityMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 13, 2023
Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study.

Anat Fisher, Jason D Kim, Colin R Dormuth

|Oct 08, 2022
How do safety warnings on medicines affect prescribing?

Barbara Mintzes, Ellen Reynolds, Priya Bahri

|Jan 27, 2022
Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept-a cohort study in British Columbia.

Anat Fisher, Jason D Kim, Greg Carney

|Oct 02, 2020
Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study.

Anat Fisher, Marie Hudson, Robert W Platt

|May 29, 2020
Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia-An interim report.

Anat Fisher, Jason D Kim, Colin R Dormuth

|Jan 09, 2020
A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia.

Colin R Dormuth, Anat Fisher, Greg Carney

Pageof 2

Frequent Collaborators

6 joint publications

Anat Fisher

4 joint publications

Greg Carney

3 joint publications

Jason D Kim

1 joint publications

Ken Bassett